EpiQuil Co-Founder receives Controlled Release Society Young Investigator Award

EpiQuil Co-Founder and Chief Scientific Officer, Scientia Associate Professor Tushar Kumeria, received the 2026 Controlled Release Society Young Investigator Award, recognising his contributions to drug delivery and advanced materials research. This international recognition reflects the scientific expertise underpinning EpiQuil's microneedle drug delivery platform.

Previous
Previous

EpiQuil selected for UNSW Health10x 2026 Accelerator